Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-436441

Options or other derivatives

  • Chief Executive Officer acquired 86,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kulkarni Samarth · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-10-26 Grant or award : show line 1 in the form Stock Option (Right to Buy) +57,500 57,500 D
2026-10-26 Grant or award : show line 2 in the form Restricted Stock Units +28,750 28,750 D
Loading xslF345X06/ownership.xml…